BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27255114)

  • 1. Transcatheter closure of PFO as secondary prevention of cryptogenic stroke.
    De Vecchis R; Baldi C; Cantatrione S
    Herz; 2017 Feb; 42(1):45-50. PubMed ID: 27255114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data.
    Hakeem A; Cilingiroglu M; Katramados A; Boudoulas KD; Iliescu C; Gundogdu B; Marmagkiolis K
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1153-1160. PubMed ID: 29332308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Nasir UB; Qureshi WT; Jogu H; Wolfe E; Dutta A; Majeed CN; Tan WA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):187-193. PubMed ID: 30905408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Closure of Patent Foramen Ovale: Randomized Trial Update.
    Arfaras-Melainis A; Palaiodimos L; Mojadidi MK
    Interv Cardiol Clin; 2019 Oct; 8(4):341-356. PubMed ID: 31445719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited.
    De Vecchis R; Baldi C
    J Clin Med Res; 2016 May; 8(5):361-6. PubMed ID: 27081420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprint of : Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Rev Neurol (Paris); 2020; 176(1-2):53-61. PubMed ID: 31787326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials.
    Riaz IB; Dhoble A; Mizyed A; Hsu CH; Husnain M; Lee JZ; Lotun K; Lee KS
    BMC Cardiovasc Disord; 2013 Dec; 13():116. PubMed ID: 24330204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies.
    Odunukan OW; Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues.
    Diener HC; Gerloff C; Thaler DE; Wöhrle J
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):92. PubMed ID: 30328522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter patent foramen ovale closure versus standard medical therapy for prevention of recurrent stroke: Updated Meta-analysis with an importance on shunt size.
    Patel K; Doshi R; Goyal H; Shah P; Meraj P
    Eur J Intern Med; 2018 Nov; 57():e31-e33. PubMed ID: 30146180
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.
    Leppert MH; Poisson SN; Carroll JD; Thaler DE; Kim CH; Orjuela KD; Ho PM; Burke JF; Campbell JD
    Stroke; 2018 Jun; 49(6):1443-1450. PubMed ID: 29720435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and ongoing controversies in PFO closure and cryptogenic stroke.
    Cheng T; Gonzalez JB; Testai FD
    Handb Clin Neurol; 2021; 177():43-56. PubMed ID: 33632456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population.
    Moon J; Kang WC; Kim S; Oh PC; Park YM; Chung WJ; Choi DY; Lee JY; Lee YB; Hwang HY; Ahn T
    Yonsei Med J; 2016 May; 57(3):621-5. PubMed ID: 26996560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.